News



Osborne Clarke advises firstminute capital on investment in Vantis

firstminute capital, together with btov, the think-cell founders and other business angels, has invested EUR 3.8 million in the health-tech...

Written on: 8th April 2021


Read time 1m

Osborne Clarke advises DSM Venturing on the $47 million Series A funding round in Meatable

International legal practice Osborne Clarke’s Netherlands team has advised DSM Venturing on the Series A Investment in Innovative food company...

Written on: 7th April 2021


Read time 1m

Osborne Clarke advises Bluu Biosciences in EUR 7 Mio financing round

Osborne Clarke has advised Berlin-based startup Bluu Biosciences in a EUR 7 million round of financing from investors including Manta...

Written on: 6th April 2021


Read time 1m

Osborne Clarke advised Hadean Ventures and Sunstone Life Science Ventures

Osborne Clarke advised Hadean Ventures and Sunstone Life Science Ventures on their investment in the second significant funding round of...

Written on: 29th March 2021


Read time 1m

Osborne Clarke advises Amphista Therapeutics on its $53M Series B funding round

International legal practice Osborne Clarke has advised Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, on...

Written on: 18th March 2021


Read time 1m

Osborne Clarke advises Science Creates Ventures on its first investment

In December 2020, Osborne Clarke advised Science Creates Ventures on the launch of Science Creates Ventures EIS Fund 1 (SCV),...

Written on: 18th March 2021


Read time 2m